The Expression Profiles of the Salvia miltiorrhiza 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase 4 Gene and Its Influence on the Biosynthesis of Tanshinones

Molecules. 2022 Jul 7;27(14):4354. doi: 10.3390/molecules27144354.

Abstract

Salvia miltiorrhiza is a medicinal plant that synthesises biologically-active tanshinones with numerous therapeutic properties. An important rate-limiting enzyme in the biosynthesis of their precursors is 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGR). This study presents the organ-specific expression profile of the S. miltiorrhiza HMGR4 gene and its sensitivity to potential regulators, viz. gibberellic acid (GA3), indole-3-acetic acid (IAA) and salicylic acid (SA). In addition, it demonstrates the importance of the HMGR4 gene, the hormone used, the plant organ, and the culture environment for the biosynthesis of tanshinones. HMGR4 overexpression was found to significantly boost the accumulation of dihydrotanshinone I (DHTI), cryptotanshinone (CT), tanshinone I (TI) and tanshinone IIA (TIIA) in roots by 0.44 to 5.39 mg/g dry weight (DW), as well as TIIA in stems and leaves. S. miltiorrhiza roots cultivated in soil demonstrated higher concentrations of the examined metabolites than those grown in vitro. GA3 caused a considerable increase in the quantity of CT (by 794.2 µg/g DW) and TIIA (by 88.1 µg/g DW) in roots. In turn, IAA significantly inhibited the biosynthesis of the studied tanshinones in root material.

Keywords: GA3; HMGR4; IAA; SA; Salvia miltiorrhiza; expression; overexpression; tanshinone.

MeSH terms

  • Abietanes
  • Acyl Coenzyme A
  • Coenzyme A
  • Furans
  • Oxidoreductases / metabolism
  • Phenanthrenes
  • Plant Roots / genetics
  • Plant Roots / metabolism
  • Quinones
  • Salvia miltiorrhiza* / metabolism
  • Salvia*

Substances

  • Abietanes
  • Acyl Coenzyme A
  • Furans
  • Phenanthrenes
  • Quinones
  • tanshinone
  • 3-hydroxy-3-methylglutaryl-coenzyme A
  • dihydrotanshinone I
  • Oxidoreductases
  • Coenzyme A

Grants and funding

This research was funded by by the Medical University of Lodz (grant nos. 502-03/3-012-02/502-34-103, 503/3-012-01/503-31-001-19-00, 503/3-015-02/503-31-001-19-00).